Industry / Malaysia
EU-Malaysia FTA Presents Hidden Opportunities Despite Negative Perceptions
May 2011 | Industry Trend AnalysisBMI View: Despite negative public perceptions, free trade agreement (FTA) talks with the EU will boost Malaysia's overall economy. Multinational pharmaceutical companies will also benefit. Key concerns include the rise in private healthcare expenses due to the patent period extension and lower government revenues from tax tariffs.
To read the full article, please choose one of the following options:
Subcribers please log in




